Effect of antihypertensive medication reduction vs usual care on short-term blood pressure control in patients aged ≥ 80 years with hypertension: the OPTiMISE randomized clinical trial
<p><strong>Importance:</strong><br /> Deprescribing of antihypertensive medications is recommended for some older patients with polypharmacy and multimorbidity when the benefits of continued treatment may not outweigh the harms.</p><br /> <p><strong>O...
Main Authors: | Sheppard, JP, Burt, J, Lown, M, Temple, E, Lowe, R, Fraser, R, Allen, J, Ford, GA, Heneghan, C, Hobbs, FDR, Jowett, S, Kodabuckus, S, Little, P, Mant, J, Mollison, J, Payne, RA, Williams, M, Yu, L-M, McManus, RJ |
---|---|
Other Authors: | The OPTiMISE Investigators |
Format: | Journal article |
Language: | English |
Published: |
American Medical Association
2020
|
Similar Items
-
Cost-effectiveness of antihypertensive deprescribing in primary care: a Markov modelling study using data from the OPTiMISE trial
by: Jowett, S, et al.
Published: (2022) -
Blood pressure changes following antihypertensive medication reduction, by drug class and dose chosen for withdrawal: exploratory analysis of data from the OPTiMISE trial
by: Sheppard, J, et al.
Published: (2021) -
Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trial
by: Sheppard, JP, et al.
Published: (2024) -
OPtimising treatment for mild Systolic hypertension in the elderly (OPTiMISE): protocol for a randomised controlled non-inferiority trial
by: Sheppard, J, et al.
Published: (2018) -
Blood Pressure Changes Following Antihypertensive Medication Reduction, by Drug Class and Dose Chosen for Withdrawal: Exploratory Analysis of Data From the OPTiMISE Trial
by: James P. Sheppard, et al.
Published: (2021-04-01)